Former Tax Accountant promoted to Executive VP, CFO at Watson Pharmaceuticals

Watson Pharmaceuticals, Inc, a global integrated pharmaceutical company, has announced that  R. Todd Joyce has been promoted to Executive Vice President, Chief Financial Officer.

Mr. Joyce was appointed Senior Vice President, Chief Financial Officer of Watson in October 2009. He joined Watson in 1997 as Corporate Controller and was named Vice President, Corporate Controller and Treasurer in 2001. During the periods October 2006 to November 2007 and from July 2009 until October 2009, Mr. Joyce served as interim Principal Financial Officer.

Prior to joining Watson, Mr. Joyce served as Vice President of Tax from 1992 to 1996 and as Vice President of Tax and Finance from 1996 until 1997 at ICN Pharmaceuticals. Prior to ICN Pharmaceuticals, Mr. Joyce served as a Certified Public Accountant with Coopers & Lybrand and Price Waterhouse. He received a B.S. in Business Administration from the University of North Carolina at Chapel Hill in 1983 and a M.S. in Taxation from Golden State University in 1992.

Watson Pharmaceuticals, Inc. is a global integrated pharmaceutical company.  The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women’s Health.  Watson has operations in many of the world’s established and growing international markets.